Forma Therapeutics Holdings (FMTX) Tops Q3 EPS by 5c; Reports Cash and Cash Equivalents of $531.8M

Forma Therapeutics Holdings (NASDAQ: FMTX) reported Q3 EPS of ($0.91), $0.05 better than the analyst estimate of ($0.96).

For earnings history and earnings-related data on Forma Therapeutics Holdings (FMTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c